Vilin Bio Med Limited (NSE:VILINBIO)

Market Cap	777.75M +128.5%
Revenue (ttm)	422.63M +185.4%
Net Income	19.29M +762.7%
EPS	1.26 +687.5%
Shares Out	15.25M
PE Ratio	42.02
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,000
Open	54.75
Previous Close	52.95
Day's Range	51.00 - 55.00
52-Week Range	18.95 - 60.95
Beta	0.63
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 30, 2026

About Vilin Bio Med

Vilin Bio Med Limited engages in the manufacture and trade of pharmaceutical products in India and internationally. It provides cardiovascular, musculo-skeletal, antibiotic, central nervous system, alimentary system, genito-urinary tract, respiratory system and anti-allergic, anti- diabetic, liquid orals, and miscellaneous drugs, as well as multi-vitamins, minerals, and amino acids supplements. The company offers its products in the form of oral liquids, dry syrups, sachets, external preparations, beta and non-beta lactam tablets and capsules, ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2005
• Country: India
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VILINBIO

Financial Performance

In fiscal year 2026, Vilin Bio Med's revenue was 422.63 million, an increase of 185.37% compared to the previous year's 148.10 million. Earnings were 19.29 million, an increase of 762.66%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 7, 2026

Data Sources Report a data error